TP53 and cancer: The available evidence suggests it is the sum of the three interacting genotypes (G/C, A-1/A-2, R/P) that give rise to the sum of the biological properties (p53 levels) of these polymorphisms that may well function as modifiers that distinguish the phenotypic differences between AA and CA cancers.